The Official News & Technical Journal Of The International Society For Pharmacoeconomics And Outcomes Research
7th Annual International Meeting Awards Recipients

Nadia Naaman, Director, Marketing & Member Services
At the ISPOR Seventh Annual International Meeting, May 19-22, 2002, Hyatt Regency Crystal City, Arlington, Virginia,
the ISPOR Awards Committee, chaired by Renée G. Goldberg Arnold PharmD recognized recipients of
ISPOR Lifetime Achievement Award, Research Excellence Awards, Contributed Paper Awards and Distinguished Service Awards.

The FIRST ISPOR Avedis Donabedian Outcomes
Research Lifetime Achievement Award

The ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award was established in honor of the late Avedis Donabedian MD, MPH to acknowledge those individuals who have made a major contribution to the improvement of health outcomes for patients or other populations. Dr. Donabedian was a renowned faculty member of the University of Michigan School of Public Health who dedicated his life to improving the quality of health care and health care systems.
After a long process that involved nominations, selection of a panel of finalists and a ranking by a committee of 35 outcomes researchers, the ISPOR Lifetime Achievement Awards Task Force, Chaired by Dean Smith PhD, selected the first recipient:
John E. Ware, Jr., PhD
CEO, Chief Science Officer & Chairman of the Board,
QualityMetric Incorporated, Lincoln, RI

 2002 ISPOR Research Excellence Awards
The recipients of the 2002 ISPOR Research Excellence Award (one for Methodology Excellence and one for Practical Application Excellence) are selected by the Awards Committee based upon publications that have appeared in respected peer-review journals and other communication venues (e.g., books, reports) during the preceding eighteen months from January 1 of the year awarded. The award selection is based upon the publication's clear description of methods, along with the appropriate and creative applications (or proposal thereof in conceptual methodology work) of techniques to answer important questions in the field of pharmacoeconomics and outcomes research. Such publications will be expected to have much impact on the field, due to their acceptance and application by others.
2002 recipient of the ISPOR Research Excellence Award for Methodology Excellence

Bernie O'Brien PhD, BA, MSc
as the senior author of the research paper:
“Is there a link in consumers' threshold value for cost-effectiveness in health care?
Health Economics 2002;11:174-80.


 
Excellence Award for Practical Application Excellence

David W. Baker MD, MPH
as senior author of the research paper:”Lack of health insurance and decline in overall health in late middle age.”New England Journal of Medicine.
345(15): 1106-12, 2001 Oct 11
A Special thanks to Newell McElwee, PharmD, MSPH, Chair, ISPOR Research Excellence Award Task Force and his committee for selecting the winners!

During the ISPOR Seventh Annual International Meeting, the scientific merit exhibited in contributed poster and podium presentations was recognized with Contributed Paper Award in the following categories: Overall, students and new investigators. This year, the ISPOR Awards Committee evaluated approximately 48 podium presentations and 350 poster presentations. Evaluations of scientific merit were based upon
the following criteria:

Renée Goldberg Arnold PharmD
Awards Commitee
  • Background provides appropriate perspective / context for the subject
  • Objectives / research questions are clearly stated
  • Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
  • Data sources and/or sampling procedures are clear and appropriate
  • Data analyses are appropriate
  • Research objectives are met/addressed
  • Implications of findings are discussed
  • Factual information is kept separate from interpretations or implications
  • Abstract is presented in an unbiased manner
  • Clarity of presentation

Podium and poster presentation award winners

BEST CONTRIBUTED PAPER AWARDS PODIUM PRESENTATIONS

MOXIFLOXACIN IV/PO MONOTHERAPY IS COST-EFFECTIVE TO THE GERMAN AND FRENCH HEALTHCARE SYSTEMS WHEN COMPARED TO IV/PO AMOXICILLIN/CLAVULANATE ± CLARITHROMYCIN IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA
Drummond M1, Becker D2, Hux M2, Chancellor J3, Duprat-Lomon I4, Sagnier PP5, 1Innovus Research (UK) Ltd. and University of York, Heslington, York, UK; 2Innovus Research Inc, Burlington, ON, Canada; 3Innovus Research (UK) Ltd, Amersham, Buckinghamshire, UK; 4Bayer Pharma, Puteaux, France; 5Bayer plc, Slough, UK

COMPARING RECENT CARDIOVASCULAR MEDICATIONS USING AN NNT MODEL
Caro J1, Ishak K2, Caro I2, Migliaccio-Walle K1, 1Caro Research Institute, Concord, MA, USA; 2Caro Research Institute, Dorval, QC, Canada

COMPARISON OF TREATMENT COST FOR DEPRESSION BETWEEN FLUOXETINE, PAROXETINE, SERTRALINE AND VENLAFAXINE USING MANAGED CARE CLAIMS DATA
Curkendall SM1, Goehring EL1, She D1, Pezzullo JC2, Jones JK1, 1The Degge Group, Ltd, Arlington, VA, USA; 2Georgetown University, Washington, DC, USA

BEST NEW INVESTIGATOR PODIUM PRESENTATION


THE BURDEN OF DEPRESSION IN CANADA
Desjardins B1, Laurier C2, 1University of Montreal, Faculty of Pharmacy, Merck Frosst Canada Ltd, Kirkland, QC; 2University of Montreal, Montreal, QC, Canada

TOTAL HEALTHCARE EXPENDITURES FOR MIGRAINE PATIENTS ASSOCIATED WITH CHOICE OF DRUG THERAPY
Schabert VF1, Esposito D1, Bowers BW2, Rousey A1, Tillotson F1, 1The MEDSTAT Group, Santa Barbara, CA, USA; 2GlaxoSmithKline, Research Triangle Park, NC, USA

IS IT COST-EFFECTIVE TO IMPROVE COMPLIANCE WITH LIPID-LOWERING THERAPY?
Benner JS1, Ganz DA1, Weinstein MC2, Neumann PJ2, Glynn RJ1, Avorn J1, 1Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA; 2Harvard School of Public Health, Boston, MA, USA

BEST STUDENT PODIUM PRESENTATION

AN ITEM ANALYSIS OF THE 24 HOUR HEADACHE DISABILITY QUESTIONNAIRE (DISQ-24) USING CLASSICAL TEST THEORY AND ITEM RESPONSE THEORY METHODS
Ayyar Krishnan A1, Kwong WJ2, 1University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 2GlaxoSmithKline, Research Triangle Park, NC, USA

FDA REGULATORY ACTIONS AGAINST MISLEADING OR UNSUBSTANTIATED ECONOMIC AND QUALITY-OF-LIFE CLAIMS: AN ANALYSIS OF WARNING LETTERS AND NOTICES OF VIOLATION
Stewart KA, Neumann PJ, Harvard School of Public Health, Boston, MA, USA

COST-EFFECTIVENESS OF NEW RAPID SCREENING TECHNOLOGIES FOR GONORRHEA IN URBAN EMERGENCY ROOM DEPARTMENTS
Aledort JE, Goldie SJ, Harvard University, Boston, MA, USA

BEST CONTRIBUTED PAPER AWARDS POSTER PRESENTATIONS

EXCESS MORTALITY AND COSTS ASSOCIATED WITH SERIOUS FUNGAL INFECTIONS AMONG ELDERLY CANCER PATIENTS: FINDINGS FROM LINKED SEER-MEDICARE DATA
Menzin J1, Lang K1, Friedman M1, Dixon D1, Marton J2, Wilson J2, 1Boston Health Economics, Waltham, MA, USA; 2Pfizer, Inc, New York, NY, USA
A BUDGET IMPACT ANALYSIS OF EARLY REFERRAL TO A NEPHROLOGIST FOR ELDERLY MEDICARE PATIENTS WITH END-STAGE RENAL DISEASE
Shih YCT1, Guo AM2, Prasad M1, Just PM2, 1MEDTAP International Inc, Bethesda, MD, USA; 2Baxter Healthcare Corporation, Deerfield, IL, USA

COST-EFFECTIVENESS OF SCREENING DONATED BLOOD WITH MINIPOOL NUCLEIC ACID TESTING (NAT) FOR HEPATITIS B VIRUS (HBV), HEPATITIS C VIRUS (HCV), AND HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Grima D1, Marshall D1, Weinstein M2, Wong J3, Kleinman S4, AuBuchon J5, 1Innovus Research Inc, Burlington, ON, Canada; 2Harvard School of Public Health, Boston, MA, USA; 3New England Medical Center, Boston, MA, USA; 4Kleinman Biomedical Research, Victoria, BC, Canada; 5Dartmouth-Hitchcock Medical Centre, Lebanon, NH, USA

Ya-Chen Tina Shih MS, PhD
Best Poster Presentation
Daniel Grima MSc
Best Poster

BEST NEW INVESTIGATOR POSTER PRESENTATION

AN ECONOMIC MODEL FOR GASTROINTESTINAL RISK STRATIFICATION COMPARING COX-2 INHIBITORS TO TRADITIONAL NSAIDS FOR ARTHRITIS TREATMENT
DeLattre ML1, Schaefer MG2, Morreale AP2, Plowman BK2, 1VA San Diego Healthcare System/University of the Pacific, San Diego, CA, USA; 2VA San Diego Healthcare System, San Diego, CA, USA

HEALTH CARE RESOURCES UTILIZATION IN CHRONIC OBSTRUCTIVE
PULMONARY DISEASE
Lachaine J1, Bradley-Kennedy C2, 1University of Montreal, Montreal, QC, Canada; 2Boehringer Ingelheim Canada Ltd, Burlington, QC, Canada

PREVENTABLE DRUG-RELATED MORBIDITY AND MORTALITY IN OLDER ADULTS: A CANADIAN COST-OF-ILLNESS MODEL
Kidney T, MacKinnon NJ, Dalhousie University, Halifax, NS, Canada

BEST STUDENT POSTER PRESENTATION

THE IMPACT OF ANTIBIOTIC SELECTION ON TREATMENT OUTCOMES FOR ACUTE OTITIS MEDIA
Ayyar Krishnan A, Christensen DB, University of North Carolina, Chapel Hill, NC, USA

ECONOMIC CONSEQUENCES OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN A NATIONAL SAMPLE OF US ADULTS
Sendersky V1, Law AW2, Gause D3, Sung J3, 1Duke University/Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA; 2Duke University, Durham, NC, USA; 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

LONG-TERM BENEFITS OF CHEMOPREVENTIVE TAMOXIFEN AND ROUTINE MAMMOGRAPHY SCREENING IN WOMEN WHO ARE AT INCREASED RISK OF BREAST CANCER
Borker R, Madhavan S, Simon K, Higa G, Amonkar M, Scott V, West Virginia University, Morgantown, WV, USA

ISPOR DISTINGUISHED SERVICE AWARDS

ISPOR Distinguished Service Awardees:
Quality of Life Special Interest Group co-chairs:
(l-r) Diane Jacqueline Wild MSc;
Joyce Cramer; Paul Kind MPhil;
Pennifer Erickson PhD; Nancy Kline

ISPOR 2001- 2002 BOARD OF DIRECTORS SERVICE AWARDS
PAST PRESIDENT
Jon Clouse RPh, MS, Executive Vice President, Ingenix Pharmaceutical Services, Eden Prairie, MN, USA
DIRECTOR (2000-2002)
A. Mark Fendrick MD, Associate Professor, University of Michigan Medical Center, Ann Arbor, MI, USA
DIRECTOR (2000-2002)
Joan Rovira PhD, Health, Nutrition and Population, The World Bank, Washington, DC, USA
DIRECTOR (2000-2002)
Kent Summers RPh, PhD, Research Scientist, Eli Lilly & Company, Lilly Corporate Center, Indianapolis, IN, USA

Board of Directors Service Awardees:
(l-r) Jon Clouse RPh, MS;
A. Mark Fendrick MD;
Kent Summers RPh, PhD.
(Joan Rovira PhD not pictured)

ISPOR DISTINGUISHED SERVICE AWARDS
SEVENTH ANNUAL INTERNATIONAL MEETING PROGRAM CHAIR


Peter Neumann ScD, Assistant Professor of Policy & Decision Sciences, Harvard School of Public Health, Boston, MA, USA

ISPOR LIFETIME ACHIEVEMENT AWARD TASK FORCE CHAIR
Dean Smith PhD, Professor, University of Michigan, Ann Arbor, MI, USA

ISPOR CONNECTIONS EDITOR-IN-CHIEF
Steven E. Marx PharmD, MS, Manager, Pharmacoeconomics & Outcomes Research, Abbott Laboratories, Lake Forset, IL, USA

VALUE IN HEALTH EDITOR-IN-CHIEF
Joel Hay PhD, Associate Professor, USC Department of Pharmaceutical Economics & Policy, Los Angeles, CA, USA

INSTITUTIONAL ADVISORY COUNCIL CHAIR
Gregory Hess MD, MBA, Consultant, Wayne, PA, USA

SHORT COURSE DEVELOPMENT & QUALITY ASSURANCE TASK FORCE CHAIR- NORTH AMERICA
Kati Copley-Merriman MS, MBA, Director of Outcomes Research, Pfizer Pharmaceuticals Group, Ann Arbor Laboratories, Ann Arbor, MI, USA

QUALITY OF LIFE SPECIAL INTEREST GROUP CHAIR
Nancy Kline Leidy PhD, RN, Vice President & Director of the Center for Health Outcomes Research, MEDTAP International, Bethesda, MD, USA

QUALITY OF LIFE SPECIAL INTEREST GROUP LEADER –
VALUES & VALUATION

Paul Kind Mphil, Senior Research Fellow, University of York, Centre for Health Economics, York, United Kingdom

QUALITY OF LIFE SPECIAL INTEREST GROUP LEADER – TRANSLATION & ADAPTATION
Diane Jacqueline Wild BSc, MSc, Partner, Oxford Outcomes, Oxford, United Kingdom

QUALITY OF LIFE SPECIAL INTEREST GROUP LEADER – CONCEPTS & DEFINITIONS
Pennifer Erickson PhD, Co-founder, O.L.G.A., State College, PA, USA

QUALITY OF LIFE SPECIAL INTEREST GROUP LEADER – INTERPRETATION & MEANING

Joyce Cramer BS, Associate Research Scientist, Yale University School of Medicine, West Haven, CT, USA

STUDENT NETWORK CHAIR
C. Denise Clemmons, University of Ilinois, Chicago, IL, USA

STUDENT NETWORK ADVISOR
Zeba Khan PhD, Senior Health Outcomes Scientist, GlaxoSmithKline, Research Triangle Park, NC, USA

UNIVERSITY OF MICHIGAN- CHAPTER PRESIDENT
Cher Beilfuss PharmD, Ann Arbor, MI, USA

UNIVERSITY OF TEXAS–CHAPTER PRESIDENT
Radhika Anantharaman MS, College of Pharmacy, Austin, TX, USA

UNIVERSITY OF TORONTO–CHAPTER PRESIDENT
Michiel Hemels PharmD, Toronto, ON, Canada, USA

UNIVERSITY OF ARIZONA–CHAPTER PRESIDENT
Vijay Joish MS, Department of Pharmaceutical Sciences, Tucson, AZ, USA

UNIVERSITY OF LOUSIANA AT MONROE–CHAPTER PRESIDENT
Anand Dalal BSPharm, School of Pharmacy, Monroe, LA, USA

FLORIDA A&M UNIVERSITY–CHAPTER PRESIDENT
C. Denise Clemmons, University of Ilinois, Chicago, IL, USA

VIRGINIA COMMONWEALTH UNIVERSITY–CHAPTER PRESIDENT
Ian Orensky, Richmond, VA, USA

OHIO STATE UNIVERSITY–CHAPTER PRESIDENT
Prashant Nikam, Columbus, OH, USA

WEST VIRGINIA UNIVERSITY–CHAPTER PRESIDENT
Jennifer Johnson RPh, Morgantown, VA, USA

THE UNIVERSITY OF NEW MEXICO–CHAPTER PRESIDENT
Shalaka Netravali BSPharm, College of Pharmacy, Albuquerque, NM, USA

THE UNIVERSITY OF TOLEDO–CHAPTER PRESIDENT

Sonalee Shah MS, Toledo, OH, USA

UNIVERSITY OF DUNDEE–CHAPTER PRESIDENT
Benjamin Ofori, Pharmacy, Dundee, Scotland, United Kingdom

Gregory Hess MD, MBA
Institutional Advisory

 
Dean Smith PhD
ISPOR Lifetime
Achievement Award Task
Joel Hay PhD
VALUE IN HEALTH
Editor-in-chief
 
  Peter Neumann ScD
7th Annual Meeting Award
Steven E. Marx PharmD, MS
ISPOR CONNECTIONS Editor-in-Chief
A SPECIAL THANKS TO Les Noe RPh, MPA, Co-Chair, ISPOR Contributed Research Paper Awards Task Force -- Poster Presentations and his committee, as well as to Mark Nuijten MD, MBA, Co-Chair, ISPOR Contributed Research Paper Awards Task Force -- Podium Presentations and his committee, for all their efforts in selecting the winners

  Issues Index | 2002 Issues Index